Chaperones in polyglutamine aggregation : beyond the Q-stretch

Detalhes bibliográficos
Autor(a) principal: Kuiper, E. F.Elsiena
Data de Publicação: 2017
Outros Autores: Mattos, Eduardo Preusser de, Jardim, Laura Bannach, Kampinga, Harm, Bergink, Steven
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UFRGS
Texto Completo: http://hdl.handle.net/10183/185182
Resumo: Expanded polyglutamine (polyQ) stretches in at least nine unrelated proteins lead to inherited neuronal dysfunction and degeneration. The expansion size in all diseases correlates with age at onset (AO) of disease and with polyQ protein aggregation, indicating that the expanded polyQ stretch is the main driving force for the disease onset. Interestingly, there is marked interpatient variability in expansion thresholds for a given disease. Between different polyQ diseases the repeat length vs. AO also indicates the existence of modulatory effects on aggregation of the upstream and downstream amino acid sequences flanking the Q expansion. This can be either due to intrinsic modulation of aggregation by the flanking regions, or due to differential interaction with other proteins, such as the components of the cellular protein quality control network. Indeed, several lines of evidence suggest that molecular chaperones have impact on the handling of different polyQ proteins. Here, we review factors differentially influencing polyQ aggregation: the Q-stretch itself, modulatory flanking sequences, interaction partners, cleavage of polyQ-containing proteins, and post-translational modifications, with a special focus on the role of molecular chaperones. By discussing typical examples of how these factors influence aggregation, we provide more insight on the variability of AO between different diseases as well as within the same polyQ disorder, on the molecular level.
id UFRGS-2_27f9f075c5c488d27bdf463db4bf637e
oai_identifier_str oai:www.lume.ufrgs.br:10183/185182
network_acronym_str UFRGS-2
network_name_str Repositório Institucional da UFRGS
repository_id_str
spelling Kuiper, E. F.ElsienaMattos, Eduardo Preusser deJardim, Laura BannachKampinga, HarmBergink, Steven2018-11-28T02:45:42Z20171662-453Xhttp://hdl.handle.net/10183/185182001082068Expanded polyglutamine (polyQ) stretches in at least nine unrelated proteins lead to inherited neuronal dysfunction and degeneration. The expansion size in all diseases correlates with age at onset (AO) of disease and with polyQ protein aggregation, indicating that the expanded polyQ stretch is the main driving force for the disease onset. Interestingly, there is marked interpatient variability in expansion thresholds for a given disease. Between different polyQ diseases the repeat length vs. AO also indicates the existence of modulatory effects on aggregation of the upstream and downstream amino acid sequences flanking the Q expansion. This can be either due to intrinsic modulation of aggregation by the flanking regions, or due to differential interaction with other proteins, such as the components of the cellular protein quality control network. Indeed, several lines of evidence suggest that molecular chaperones have impact on the handling of different polyQ proteins. Here, we review factors differentially influencing polyQ aggregation: the Q-stretch itself, modulatory flanking sequences, interaction partners, cleavage of polyQ-containing proteins, and post-translational modifications, with a special focus on the role of molecular chaperones. By discussing typical examples of how these factors influence aggregation, we provide more insight on the variability of AO between different diseases as well as within the same polyQ disorder, on the molecular level.application/pdfengFrontiers in neuroscience. Lausanne. vol. 11 (Mar. 2017), 145, 11 f.Doença de HuntingtonDoença de Machado-JosephChaperonas molecularesAggregationHuntington’s diseaseMachado-Joseph diseaseMolecular chaperonesPolyglutamine diseaseChaperones in polyglutamine aggregation : beyond the Q-stretchEstrangeiroinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSTEXT001082068.pdf.txt001082068.pdf.txtExtracted Texttext/plain72652http://www.lume.ufrgs.br/bitstream/10183/185182/2/001082068.pdf.txt12c2943a5cbd11fc5bb078248ac08180MD52ORIGINAL001082068.pdfTexto completo (inglês)application/pdf1117172http://www.lume.ufrgs.br/bitstream/10183/185182/1/001082068.pdfb65a2d1d4a8117e0149641cdff3c2c0dMD5110183/1851822018-11-29 02:46:47.804902oai:www.lume.ufrgs.br:10183/185182Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2018-11-29T04:46:47Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.pt_BR.fl_str_mv Chaperones in polyglutamine aggregation : beyond the Q-stretch
title Chaperones in polyglutamine aggregation : beyond the Q-stretch
spellingShingle Chaperones in polyglutamine aggregation : beyond the Q-stretch
Kuiper, E. F.Elsiena
Doença de Huntington
Doença de Machado-Joseph
Chaperonas moleculares
Aggregation
Huntington’s disease
Machado-Joseph disease
Molecular chaperones
Polyglutamine disease
title_short Chaperones in polyglutamine aggregation : beyond the Q-stretch
title_full Chaperones in polyglutamine aggregation : beyond the Q-stretch
title_fullStr Chaperones in polyglutamine aggregation : beyond the Q-stretch
title_full_unstemmed Chaperones in polyglutamine aggregation : beyond the Q-stretch
title_sort Chaperones in polyglutamine aggregation : beyond the Q-stretch
author Kuiper, E. F.Elsiena
author_facet Kuiper, E. F.Elsiena
Mattos, Eduardo Preusser de
Jardim, Laura Bannach
Kampinga, Harm
Bergink, Steven
author_role author
author2 Mattos, Eduardo Preusser de
Jardim, Laura Bannach
Kampinga, Harm
Bergink, Steven
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Kuiper, E. F.Elsiena
Mattos, Eduardo Preusser de
Jardim, Laura Bannach
Kampinga, Harm
Bergink, Steven
dc.subject.por.fl_str_mv Doença de Huntington
Doença de Machado-Joseph
Chaperonas moleculares
topic Doença de Huntington
Doença de Machado-Joseph
Chaperonas moleculares
Aggregation
Huntington’s disease
Machado-Joseph disease
Molecular chaperones
Polyglutamine disease
dc.subject.eng.fl_str_mv Aggregation
Huntington’s disease
Machado-Joseph disease
Molecular chaperones
Polyglutamine disease
description Expanded polyglutamine (polyQ) stretches in at least nine unrelated proteins lead to inherited neuronal dysfunction and degeneration. The expansion size in all diseases correlates with age at onset (AO) of disease and with polyQ protein aggregation, indicating that the expanded polyQ stretch is the main driving force for the disease onset. Interestingly, there is marked interpatient variability in expansion thresholds for a given disease. Between different polyQ diseases the repeat length vs. AO also indicates the existence of modulatory effects on aggregation of the upstream and downstream amino acid sequences flanking the Q expansion. This can be either due to intrinsic modulation of aggregation by the flanking regions, or due to differential interaction with other proteins, such as the components of the cellular protein quality control network. Indeed, several lines of evidence suggest that molecular chaperones have impact on the handling of different polyQ proteins. Here, we review factors differentially influencing polyQ aggregation: the Q-stretch itself, modulatory flanking sequences, interaction partners, cleavage of polyQ-containing proteins, and post-translational modifications, with a special focus on the role of molecular chaperones. By discussing typical examples of how these factors influence aggregation, we provide more insight on the variability of AO between different diseases as well as within the same polyQ disorder, on the molecular level.
publishDate 2017
dc.date.issued.fl_str_mv 2017
dc.date.accessioned.fl_str_mv 2018-11-28T02:45:42Z
dc.type.driver.fl_str_mv Estrangeiro
info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10183/185182
dc.identifier.issn.pt_BR.fl_str_mv 1662-453X
dc.identifier.nrb.pt_BR.fl_str_mv 001082068
identifier_str_mv 1662-453X
001082068
url http://hdl.handle.net/10183/185182
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.pt_BR.fl_str_mv Frontiers in neuroscience. Lausanne. vol. 11 (Mar. 2017), 145, 11 f.
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFRGS
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Repositório Institucional da UFRGS
collection Repositório Institucional da UFRGS
bitstream.url.fl_str_mv http://www.lume.ufrgs.br/bitstream/10183/185182/2/001082068.pdf.txt
http://www.lume.ufrgs.br/bitstream/10183/185182/1/001082068.pdf
bitstream.checksum.fl_str_mv 12c2943a5cbd11fc5bb078248ac08180
b65a2d1d4a8117e0149641cdff3c2c0d
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv
_version_ 1801224956841820160